“Through close collaboration with manufacturers, we have addressed critical unmet needs by developing practical solutions that make available and effective drug-resistant TB treatments not only ...

As if these challenges weren’t already enough, the emergence of multidrug-resistant TB (MDR-TB)—resulting from inadequate treatment regimens and poor adherence to TB therapy—has further ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...

"By: locked contentwith Kuensel 20 medical locked contentbe Thimphu regimen."By: be locked content20 environment medical (MDR-TB) locked contentregimen."By: Yak be shorter locked content medical ...

National referral hospital in Thimphu will implement the shorter regimen of multi-drug-resistant tuberculosis (MDR-TB) treatment with enrollment of 15 MDR-TB patients from April. As per the updated ...

While traditional MDR-TB treatments can last up to 20 months with severe side effects, the BPaLM regime cures drug-resistant TB in just six months. India is also partnering with the private sector ...

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not ...

Preventing the development of drug-resistant TB through a good control program based on directly observed treatment, short-course, is of paramount importance. Established multidrug-resistant (MDR ...

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...